the canadian glycomics network (glyconet) is a network of centres of excellence that focuses on the role of glycans (carbohydrates) in health. areas of focus are neurodegenerative diseases, infectious diseases, chronic diseases, in particular diabetes & obesity, genetic diseases involving errors in glycan metabolism, and cancer. additional information about network research can be found at www.glyconet.ca. a key goal of glyconet is the translation of research advances into novel products for treating disease. accordingly this request for proposals seeks to fund more mature projects needing network support to de-risk and advance them to a state at which translation is possible.

these grants further advance/translate projects with proof of concept and protected ip. maximum request: $150,000 for one year, 1:1 matching required.

idea development award – preproposal due date may 11, 2020

established investigators: independent investigators at or above the level of assistant professor (or equivalent) and 10 years or more from first faculty appointment (or equivalent) at the time of the application submission or

early career investigators:
independent investigators at the level of assistant professor (or equivalent) and less than 10 years from his/her first faculty appointment (or equivalent) at the time of application submission deadline are eligible.

• pre-application is required; full application submission is by invitation only.
• supports innovative ideas and high-impact approaches based on scientifically sound evidence to move toward the vision to understand and cure bone marrow failure (bmf).
• proposed research should have a high probability of revealing new avenues of investigation.
• research project should include well-formulated, testable hypothesis and a well-developed and articulated research approach.
• strong bmf research team.
• may include relevant preliminary data.
• clinical trials will not be supported.
• the maximum allowable funding for the entire period of performance is $325,000 in direct costs (plus indirect costs).
• the maximum period of performance is 2 years.

a pre-application is required and must be submitted through the electronic biomedical research application portal (ebrap) at https://ebrap.org prior to the pre-application deadline. all applications must conform to the final program announcement and general application instructions that will be available for electronic downloading from the grants.gov website. the application package containing the required forms for the award mechanism will also be found on grants.gov. a listing of all cdmrp and other usamrdc extramural funding opportunities can be obtained on the grants.gov website by performing a basic search using cfda number 12.420. 

for email notification when program announcements are released, subscribe to program-specific news and updates under “email subscriptions” on the ebrap homepage at https://ebrap.org. for more information about the bmfrp or other cdmrp-administered programs, please visit the cdmrp website (https://cdmrp.army.mil).

point of contact:

cdmrp help desk

301-682-5507 
help@ebrap.org

we are seeking innovative solutions that accelerate the improvement of coverage, reach, efficiency, and effectiveness of mass health campaigns that deliver health products or services in low-and middle-income countries, specifically through improved planning/microplanning and focus on unreached populations.

specifically, we are looking for innovations in approaches, practices, or tools that dramatically improve the planning/microplanning that will lead to improved effectiveness of campaigns. we are also looking for innovative tools and technologies to more effectively identify and reach the most vulnerable populationswhen countries are designing and implementing mass campaigns.

we seek fundamentally transformative and innovative ideas to support the design and development of new mhh products that meet key criteria of being responsive to user needs - particularly in lmic context; with priority focus on safety, unobtrusiveness, effectiveness (no leaking), cultural acceptability, and sustainability. while there are a number of challenges related to access to current products, reducing stigma, and shifting social norms, this opportunity is specifically focused on driving transformative innovation in the product development domain. we are particularly seeking new technologies, including those potentially used in adjacent fields such as materials science, that could be adapted to innovative mhh products. we fully recognize that technology alone does not automatically improve people's lives. thus, these creative solutions must be contextually grounded and designed in response to the needs and preferences of women and girls living in lmic and designed particularly with the future in mind.

we invite proposals for interventions to address the following challenges related to the cesarean section:

1. increasing access to cesarean section where it is currently inadequate
2. increasing quality and safety of cesarean section to reduce iatrogenic harm to both mothers and newborns
3. reducing rates of non-medically indicated cesarean section.

interventions addressing more than one challenge (e.g. quality and access) are encouraged. in some geographies all three of these challenges exist simultaneously, at different times for different populations; in other geographies only one or two of these challenges predominate. applications should clearly state which of these three challenges is being targeted and provide clear rationale for why the intervention is likely to address the challenge. we are particularly interested in geographies with high fertility and weak health systems that will face challenges to ensure the provision of safe c-sections can keep pace with medical need, and we will thus consider applications proposing activities to be implemented in sub-saharan africa or south asia (india, pakistan, bangladesh).

the bill & melinda gates foundation is committed to a long-term vision of expanding contraceptive options for the most vulnerable women in low-resource settings through development of new methods that better align with women’s preferences. contraceptive product innovation will be required to achieve this goal. specifically, the emphasis for this work is on developing safe and effective non-hormonal contraceptive agents with both improved overall tolerability and a side effect profile differentiated from hormonal methods. this emphasis is based on an understanding that overall tolerability of and side effects from hormonal methods present real and meaningful barriers to women realizing their reproductive intentions.

the canadian bar law for the future fund (lfff) has grants available for innovative projects in the field of law.

projects eligible for consideration must be of national interest and/or of benefit to the general public and must be in at least one of the following fields:

• legal research
• legal education
• legislation and law reform
• administration of justice

lfff does not provide funding for capital projects, ongoing operating expenses, budget deficits, general fund drives, annual charitable appeals, scholarships, sabbaticals, conferences and seminars, nor applications relating exclusively to publication costs, equipment purchases or travel costs. no permanent commitments are made in support of a project, and no grants are made that would result in financial gain to an individual or organization. more detailed grant application information.

bbrf young investigator grants provide each scientist with up to $35,000 per year for two years totaling $70,000 to enable promising investigators to either extend research fellowship training or begin careers as independent research faculty. the brain & behavior research foundation awarded the first young investigator grant in 1987. the goal of the yi program is to help researchers launch careers in neuroscience and psychiatry and gather pilot data to apply for larger federal and university grants. since 1987, we have awarded more than $243 million in young investigator grants around the world.

background